|
1
|
Ebisch RMF, Rutten DWF, IntHout J,
Melchers WJG, Massuger LFAG, Bulten J, Bekkers RLM and Siebers AG:
Long-lasting increased risk of human papillomavirus-related
carcinomas and premalignancies after cervical intraepithelial
neoplasia grade 3: A population-based cohort study. J Clin Oncol.
35:2542–2550. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kocken M, Helmerhorst TJ, Berkhof J,
Louwers JA, Nobbenhuis MA, Bais AG, Hogewoning CJ, Zaal A,
Verheijen RH, Snijders PJ and Meijer CJ: Risk of recurrent
high-grade cervical intraepithelial neoplasia after successful
treatment: A long-term multi-cohort study. Lancet Oncol.
12:441–450. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoffman SR, Le T, Lockhart A, Sanusi A,
Dal Santo L, Davis M, McKinney DA, Brown M, Poole C, Willame C and
Smith JS: Patterns of persistent HPV infection after treatment for
cervical intraepithelial neoplasia (CIN): A systematic review. Int
J Cancer. 141:8–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arbyn M, Ronco G, Anttila A, Meijer CJ,
Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R
and Peto J: Evidence regarding human papillomavirus testing in
secondary prevention of cervical cancer. Vaccine. 30 (Suppl
5):F88–F99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bruhn LV, Andersen SJ and Hariri J:
HPV-testing versus HPV-cytology co-testing to predict the outcome
after conization. Acta Obstet Gynecol Scand. 97:758–765. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arbyn M, Verdoodt F, Snijders PJ, Verhoef
VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao F,
et al: Accuracy of human papillomavirus testing on self-collected
versus clinician-collected samples: A meta-analysis. Lancet Oncol.
15:172–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arbyn M, Snijders PJ, Meijer CJ, Berkhof
J, Cuschieri K, Kocjan BJ and Poljak M: Which high-risk HPV assays
fulfill criteria for use in primary cervical cancer screening? Clin
Microbiol Infect. 21:817–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jentschke M, Chen K, Arbyn M, Hertel B,
Noskowicz M, Soergel P and Hillemans P: Direct comparison of two
vaginal self-sampling devices for the detection of human
papillomavirus infections. J Clin Virol. 82:46–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Östensson E, Hellström AC, Hellman K,
Gustavsson I, Gyllensten U, Wilander E, Zethraeus N and Andersson
S: Projected cost-effectiveness of repeat HPV testing using
self-collected vaginal samples in the Swedish cervical cancer
screening program. Acta Obstet Gynecol Scand. 92:830–840. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Andersson S, Belkić K, Mints M and
Östensson E: Is self-sampling to test for high-risk papillomavirus
an acceptable option among women who have been treated for
high-grade cervical intraepithelial neoplasia? PLoS One.
13:e01990382018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andersson S, Belkić K, Safer Demirbüker
SS, Mints M and Östensson E: Perceived cervical cancer risk among
women treated for high-grade cervical intraepithelial neoplasia:
The importance of specific knowledge. PLoS One. 12:e1901562017.
View Article : Google Scholar
|
|
12
|
Richart RM: Cervical intraepithelial
neoplasia. Pathol Annu. 8:301–328. 1973.PubMed/NCBI
|
|
13
|
Jordan J, Martin-Hirsch P, Arbyn M,
Schenck U, Baldauf JJ, Da Silva D, Anttila A, Nieminen P and
Prendiville W: European guidelines for clinical management of
abnormal cervical cytology, part-2. Cytopathology. 20:5–16. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et
al: The 2001 Bethesda system: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brismar S, Johansson B, Borjesson M, Arbyn
M and Andersson S: Follow-up after treatment of cervical
intraepithelial neoplasia by human papillomavirus genotyping. Am J
Obstet Gynecol. 201:17.e1–8. 2009. View Article : Google Scholar
|
|
16
|
Kocken M, Uijterwaal MH, de Vries AL,
Berkhof J, Ket JC, Helmerhorst TJ and Meijer CJ: High-risk human
papillomavirus testing versus cytology in predicting post-treatment
disease in women treated for high-grade cervical disease: A
systematic review and meta-analysis. Gynecol Oncol. 125:500–507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Persson M, Brismar Wendel S, Ljungblad L,
Johansson B, Weiderpass E and Andersson S: High-risk human
papillomavirus E6/E7 mRNA and L1 DNA as markers of
residual/recurrent cervical intraepithelial neoplasia. Oncol Rep.
28:346–352. 2012.PubMed/NCBI
|
|
18
|
Asciutto KC, Henic E, Darlin L, Forslund O
and Borgfeldt C: Follow up with HPV test and cytology as test of
cure, 6 months after conization, is reliable. Acta Obstet Gynecol
Scand. 95:1251–1257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garutti P, Borghi C, Bedoni C, Bonaccorsi
G, Greco P, Tognon M and Martini F: HPV-based strategy in follow-up
of patients treated for high-grade cervical intra-epithelial
neoplasia: 5-year results in a public health surveillance setting.
Eur J Obstet Gynecol Reprod Biol. 210:236–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saville M, Hawkes D, Keung M, Ip E,
Silvers J, Sultana F, Malloy MJ, Velentzis LS, Canfel LK, Wrede CD
and Brotherton J: Analytical performance of HPV assays on vaginal
self-collected vs. practitioner-collected cervical samples. J Clin
Virol. 127:1043752020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Norman I, Hjerpe A and Dillner J: Risk of
high-grade lesions after atypical glandular cells in cervical
screening: A population-based cohort study. BMJ Open.
7:e0170702017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patadji S, Li Z, Pradhan D and Zhao C:
Significance of high-risk HPV detection in women with atypical
glandular cells on pap testing: Analysis of 1857 cases from an
academic institution. Cancer Cytopathol. 125:205–211. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andersson S, Larson B, Hjerpe A,
Silfverswärd C, Sällström J, Wilander E and Rylander E:
Adenocarcinoma of the uterine cervix: The presence of human
papillomavirus and the method of detection. Acta Obstet Gynecol
Scand. 82:960–965. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dahlström LA, Ylitalo N, Sundström K,
Palmgren J, Ploner A, Eloranta S, Sanjeevi CB, Andersson S, Rohan
T, Dillner J, et al: Prospective study of human papillomavirus and
risk of cervical adenocarcinoma. Int J Cancer. 127:1923–1930. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fambrini M, Penna C, Pieralli A, Bussani
C, Fallani MG, Andersson KL, Scarselli G and Marchionni M: PCR
detection rates of high risk human papillomavirus DNA in paired
self-collected urine and cervical scrapes after laser CO2
conization for high-grade cervical intraepithelial neoplasia.
Gynecol Oncol. 109:59–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rohner E, Rahangdale L, Sanusi B, Knittel
AK, Vaughan L, Chesko K, Faherty B, Tulenko SE, Schmitt JW, Romocki
LS, et al: Test accuracy of human papillomavirus in urine for
detection of cervical intraepithelial neoplasia. J Clin Microbiol.
58:e01443–19. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vorsters A, Van Damme P and Clifford G:
Urine testing for HPV: Rationale for using first void. BMJ.
349:g62522014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pathak N, Dodds J, Zamora J and Khan K:
Accuracy of urinary human papillomavirus testing for presence of
cervical HPV: Systematic review and meta-analysis. BMJ.
349:g52642014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pattyn J, Van Keer S, Biesmans S, Ieven M,
Vanderborght C, Beyers K, Vankerckhoven V, Bruyndonckx R, Van Damme
P and Vorsters A: Human papillomavirus detection in urine: Effect
of a first-void urine collection device and timing of collection. J
Virol Methods. 264:23–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vorsters A, Micalessi I, Bilcke J, Ieven
M, Bogers J and Van Damme P: Detection of human papillomavirus DNA
in urine. A review of the literature. Eur J Clin Microbiol Infect
Dis. 31:627–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fröberg M, Östensson E, Belkić K, Oštrbenk
A, Poljak M, Mints M, Arbyn M and Andersson S: Impact of the human
papillomavirus status on development of high-grade cervical
intraepithelial neoplasia in women negative for intraepithelial
lesions or malignancy at baseline: A 9-year Swedish nested
case-control follow-up study. Cancer. 125:239–248. 2019.PubMed/NCBI
|
|
32
|
Baasland I, Hagen B, Vogt C, Valla M and
Romundstad PR: Colposcopy and additive diagnostic value of biopsies
from colposcopy-negative areas to detect cervical dysplasia. Acta
Obstet Gynecol Scand. 95:1258–1263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Andersson S, Belkić K, Mints M and
Östensson E: Acceptance of self-sampling among long-term cervical
screening non-attenders with HPV positive results: Promising
opportunity for specific cancer education. J Cancer Educ.
36:126–133. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Galbraith KV, Gilkey MB, Smith JS, Richman
AR, Barclay L and Brewer NT: Perceptions of mailed HPV self-testing
among women at higher risk for cervical cancer. J Community Health.
39:849–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Crofts V, Flahault E, Tebeu PM, Untiet S,
Fosso GK, Boulvain M, Vassilakos P and Petignat P: Education
efforts may contribute to wider acceptance of human papillomavirus
self-sampling. Int J Womens Health. 7:149–154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arrossi S, Ramos S, Straw C, Thouyaret L
and Orellana L: HPV testing: A mixed-method approach to understand
why women prefer self-collection in a middle-income country. BMC
Public Health. 16:8322016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma'som M, Bhoo-Pathy N, Nasir NH,
Bellinson J, Subramaniam S, Ma Y, Yap SH, Goh PP, Gravitt P and Woo
YL: Attitudes and factors affecting acceptability of
self-administered cervicovaginal sampling for human papillomavirus
(HPV) genotyping as an alternative to Pap testing among multiethnic
Malaysian women. BMJ Open. 6:e0110222016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vahabi M and Lofters A: Muslim immigrant
women's views on cervical cancer screening and HPV self-sampling in
Ontario, Canada. BMC Public Health. 16:8682016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Racey CS and Gesink DC: Barriers and
facilitators to cervical cancer screening among women in rural
Ontario, Canada: The role of self-collected HPV testing. J Rural
Health. 32:136–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
de Melo Kuil L, Lorenzi AT, Stein MD,
Resende JCP, Antoniazzi M, Longatto-Filho A, Scapulatempo-Neto C
and Fregnani JHTG: The role of self-collection by vaginal lavage
for the detection of HPV and high-grade intraepithelial neoplasia.
Acta Cytol. 61:425–433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mao C, Kulasingam SL, Whitham HK, Hawes
SE, Lin J and Kiviat NB: Clinician and patient acceptability of
self-collected human papillomavirus testing for cervical cancer
screening. J Womens Health (Larchmt). 26:609–615. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bergengren L, Kaliff M, Larsson GL,
Karlsson MG and Helenius G: Comparison between professional
sampling and self-sampling for HPV-based cervical cancer screening
among postmenopausal women. Int J Gynecol Obstet. 142:359–364.
2018. View Article : Google Scholar
|
|
43
|
Kahn JA, Slap GB, Bernstein DI, Kollar LM,
Tissot AM, Hillard PA and Rosenthal SL: Psychological, behavioral,
and interpersonal impact of human papillomavirus and pap test
results. J Womens Health (Larchmt). 14:650–659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Luszczynska A, Durawa AB, Scholz U and
Knoll N: Empowerment beliefs and intention to uptake cervical
cancer screening: Three psychosocial mediating mechanisms. Women
Health. 52:162–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
